Freshpet, Inc. filings document formal disclosures for its refrigerated fresh pet food business, with recurring 8-K reports on quarterly and annual results, Regulation FD presentations, and reconciliations of non-GAAP measures such as adjusted gross profit, adjusted EBITDA, and free cash flow. The filings connect operating results to net sales, gross margin, input costs, plant expenses, and outlook commentary.
Proxy and compensation-related filings cover annual meeting matters, board governance, executive compensation, equity incentive awards, restricted stock units, inducement grants, and officer transitions. These documents also describe the company’s common stock, shareholder voting procedures, governance committees, and management accountability for Freshpet’s growth strategy and refrigerated distribution model.
Freshpet, Inc. (FRPT) chief executive officer William B. Cyr reported option exercises and related share sales. On August 14, 2026, he and related entities exercised options for a total of 84,000 shares of common stock at an exercise price of $10.23 per share under the 2014 Omnibus Incentive Plan, then sold 44,069 shares of common stock in open-market transactions around $72.9 per share. Some shares are held indirectly through his spouse and family trusts, and the sales were made under a Rule 10b5-1 trading plan adopted on November 5, 2025.
FRPT insiders and related trusts filed a notice of proposed sales of common stock under Form 144. One planned transaction lists 1,123 shares tied to a stock option exercise dated 08/17/2026. The filing also lists multiple prior common stock sales during the past three months by The Linda W Cyr 2020 Irrevocable Trust For Descendants, The William B Cyr 2020 Irrevocable Spousal Trust, Linda W. Cyr, and William B. Cyr, each with specified share amounts and aggregate sale values on several May and August 2026 trade dates.
Freshpet, Inc. insider-related parties filed a notice to sell 41,022 shares of common stock under Rule 144. These shares are to be acquired from the issuer on 08/17/2026 through a Stock Option Exercise paid in cash, then made available for potential sale on NASDAQ.
The filing also lists multiple open market sales of common stock during May and August 2026 by William B. Cyr, Linda W. Cyr, and two related irrevocable trusts, with individual transactions of around 40,000–43,000 shares for William B. Cyr and smaller blocks for the other entities.
A shareholder of FRPT, using Fidelity Brokerage Services LLC as broker, filed a notice covering the potential public resale of 1,922 common shares on or after August 17, 2026 on NASDAQ. These shares are to be acquired from the issuer for cash via a stock option exercise on the same date.
The filing also lists prior sales of FRPT common stock during the past three months by William B. Cyr, Linda W. Cyr, and two related irrevocable trusts, including multiple transactions in May 2026 and August 14, 2026, each involving tens of thousands of shares and multi-million-dollar aggregate proceeds for William B. Cyr.
A holder associated with ticker FRPT filed a notice to sell common stock under Rule 144. The filing lists a proposed sale of 41,023 shares of common stock through Fidelity Brokerage Services, tied to a stock option exercise dated 08/14/2026, plus several earlier cash sales in May 2026 by related parties and trusts.
Freshpet, Inc. insider-related entities filed to sell 1,922 shares of Common Stock, expected to be delivered through a stock option exercise on 08/14/2026, with brokerage handled by Fidelity Brokerage Services LLC and the shares listed on NASDAQ.
The filing also lists multiple recent sales of Common Stock during May 2026 by William B. Cyr, Linda W. Cyr, and two 2020 irrevocable trusts associated with them, each entry showing specific dates, share counts, and aggregate dollar amounts.
FRPT insiders and related trusts filed to sell common stock. A brokerage account at Fidelity Brokerage Services is listed to sell 1,124 shares of common stock on 08/14/2026 on NASDAQ, following a stock option exercise paid in cash. The notice also lists multiple common-stock sales during May 2026 by William B. Cyr, Linda W. Cyr, and associated irrevocable and spousal trusts, each with specified share amounts and dollar proceeds.
Freshpet, Inc. reported strong growth for the three and six months ended June 30, 2026. Net sales were $305,587 for the quarter and $603,231 year-to-date, rising 15.5% and 14.3% from 2025, driven by volume gains across Grocery, Mass, International, Digital, Pet Specialty and Club channels.
Quarterly gross margin improved to 42.1%, with Adjusted Gross Margin at 48.6%. Adjusted EBITDA reached $52,200 for the quarter (17.1% of net sales) and $90,073 year-to-date. A sale of a non-controlling equity investment generated a pre-tax gain of $66,552, lifting six-month net income to $67,996 versus $3,659 a year earlier.
Cash and cash equivalents increased to $350,809 as of June 30, 2026, supported by $84,754 in operating cash flow and $99,998 of equity sale proceeds. The company reports $398,443 of carrying value for its 3.0% Convertible Senior Notes and has begun a $150,000 share repurchase program, buying 1,032 shares for $54,565 year-to-date.
Freshpet, Inc. reported strong Q2 2026 results, with net sales of $305.6 million, up 15.5% year over year on 15.7% higher volume and slightly unfavorable price/mix. GAAP gross margin improved to 42.1%, and Adjusted Gross Margin reached 48.6%. Net income was $19.5 million and Adjusted EBITDA $52.2 million.
For the first six months of 2026, net sales rose to $603.2 million and net income to $68.0 million, largely aided by a $66.552 million gain on the sale of a non‑controlling equity investment, alongside higher sales and lower non‑recurring SG&A charges.
Cash and cash equivalents were $350.8 million at June 30, 2026 against $398.4 million of convertible senior notes, and Free Cash Flow turned positive at $27.4 million. Management raised 2026 guidance to 10–12% net sales growth and $210–$220 million Adjusted EBITDA and increased its 2027 Adjusted Gross Margin target to at least 49%.
Wasatch Advisors has filed Amendment No. 2 to a beneficial ownership report for Freshpet Inc., stating beneficial ownership of 2,819,293 shares of Freshpet common stock, representing 5.7% of the outstanding class.
Wasatch Advisors reports sole voting power over 1,999,682 shares and sole dispositive power over all 2,819,293 shares, with no shared voting or shared dispositive power. The filing is signed by CEO Mike Yeates.